The invention relates to sarcoma-associated antigens and the nucleic acid
molecules that encode them. The invention further relates to the use of
the nucleic acid molecules, polypeptides and fragments thereof associated
with sarcoma in methods and compositions for the diagnosis and treatment
of diseases, such as cancer. More specifically, the invention relates to
the discovery of a novel cancer/testis (CT) antigen, NY-SAR-35.